The association between polymorphisms in insulin and obesity related genes and risk of colorectal cancer

Iranian Journal of Cancer Prevention

Volumn 6, Issue 4, 2013, Pages 179-185

  Rezaei Tavirani, Mostafa ^a   Safaei, Akram ^b   Zali, Mohammad Reza ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colorectal cancer; Insulin; Obesity

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; INSULIN; INSULIN RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C;

ADIPO GENE; ADIPOR GENE; BIOAVAILABILITY; CANCER GROWTH; CANCER INHIBITION; CANCER RISK; CELL PROLIFERATION; CELL SURVIVAL; COLON CARCINOGENESIS; COLORECTAL CANCER; CORRELATION ANALYSIS; DISEASE ASSOCIATION; GENE; GENETIC POLYMORPHISM; HUMAN; HYPERINSULINEMIA; IGF GENE; IGFBP GENE; INS GENE; INSR GENE; INSULIN RESISTANCE; LEP GENE; LEPR GENE; OBESITY; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 84888400098     PISSN: 20082401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Slattery ML, Fitzpatrick F. Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology. Cancer Prevention Research. 2009; 2(11):922-930.
2. Li S, Liu H, Jia Y, Deng Y, Zhang L, Lu Z, et al. A Novel SNPs Detection Method Based on Gold Magnetic Nanoparticles Array and Single Base Extension. Theranostics. 2012; 2(10):967-975.
3. Kirsten F, Karl-Heinz G, Angela R, Agnes HW. Genome-wide prediction of splice-modifying SNPs in human genes using a new analysis pipeline called AASsites. BMC Bioinformatics. 2011; 12(Suppl 4):S2.
4. Barash CI. Ethical issues in Pharmacogenetics. Drugs. 2001.
5. Hoyo C, Murphy SK, Schildkraut JM, Vidal AC, Skaar D, Millikan RC, et al. IGF2R genetic variants, circulating IGF2 concentrations and colon cancer risk in African Americans and Whites. Disease Markers. 2012; 32(2):133-141.
6. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiology Biomarkers & Prevention. 2002;11(4):385-391.
7. Risch N. The Genetic Epidemiology of Cancer Interpreting Family and Twin Studies and Their Implications for Molecular Genetic Approaches. Cancer Epidemiology Biomarkers & Prevention. 2001; 10(7):733-741.
8. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. New England Journal of Medicine. 2000; 343(2):78-85.
9. Lynch HT, de la Chapelle. Hereditary colorectal cancer. N Engl J Med. 2003; 348(10):919-932.
10. De la Chapelle A. Genetic predisposition to colorectal cancer. Nature Reviews Cancer. 2004; 4(10):769-780.
11. Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science (New York, NY). 1993; 260(5109):812-816.
12. Sporn MB, Todaro GJ. Autocrine secretion and malignant transformation of cells. New England Journal of Medicine.1980; 303(15):878-880.
13. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. Journal of the National Cancer Institute. 2000; 92(18):1472-1489.
14. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. Journal of the National Cancer Institute. 1999; 91(7):620-625.
15. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiology Biomarkers & Prevention. 2000; 9(4):345-349.
16. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. Journal of the National Cancer Institute. 2000; 92(19):1592-1600.
17. Arkani M, Safaei A, Karimi K, Vahedi M, Mohebi SR, Fatemi SR, et al. Association of IGF-1 gene (rs5742612) polymorphism with colorectal cancer. Journal of Sabzevar University of Medical Sciences. 2012; 19(2):109-115.
18. Zecevic M, Amos CI, Gu X, Campos IM, Jones JS, Lynch PM, et al. IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer. Journal of the National Cancer Institute. 2006; 98(2):139-143.
19. Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD. Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer Epidemiology Biomarkers & Prevention. 2005; 14(5):1204-1211.
20. Maki RG. Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. Journal of Clinical Oncology. 2010; 28(33):4985-95.
21. Xiang H, Wang Y, Nie S. Meta-Analysis of the Association between Insulin-Like Growth Factor Binding Protein 3 Genetic Polymorphisms and Colorectal Cancer Susceptibility. PLoS One. 2013; 8(3):e59665.
22. Jenkins P, Frajese V, Jones A, Camacho-Hubner C, Lowe D, Fairclough P, et al. Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. Journal of Clinical Endocrinology & Metabolism. 2000; 85(9):3218-3221.
23. Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J. The Combination of Insulin-Like Growth Factor I and Insulin-Like Growth Factor-Binding Protein-3 Reduces Insulin Requirements in Insulin-Dependent Type 1 Diabetes: Evidence for in VivoBiological Activity. Journal of Clinical Endocrinology & Metabolism. 2000; 85(4):1518-1524.
24. Lönn S, Rothman N, Shapiro WR, Fine HA, Selker RG, Black PM, et al. Genetic variation in insulin-like growth factors and brain tumor risk. Neuro-oncology. 2008; 10(4):553-559.
25. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nature Reviews Cancer. 2004; 4:18-505.
26. Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. Journal of cellular physiology. 2000; 183(1):1-9.
27. Fürstenberger G, Senn HJ. Insulin-like growth factors and cancer. The lancet oncology. 2002; 3(5):298-302.
28. Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. Journal of the National Cancer Institute. 2002; 94(13):972-980.
29. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. The Journal of nutrition. 2001; 131(11):3109S-3120S.
30. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nature Reviews Cancer. 2008; 8(12):915-928.
31. Le Stunff C, Fallin D, Schork NJ, Bougnères P. The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity. Nature genetics. 2000; 26(4):444-6.
32. Ortiz AP, Thompson CL, Chak A, Berger NA, Li L. Insulin resistance, central obesity, and risk of colorectal adenomas. Cancer. 2011; 118(7):1774-1781.
33. Gunter MJ, Hayes RB, Chatterjee N, Yeager M, Welch R, Schoen RE, et al. Insulin resistance-related genes and advanced left-sided colorectal adenoma. Cancer Epidemiology Biomarkers & Prevention. 2007; 16(4):703-708.
34. Koohestani N, Tran TT, Lee W, Wolever TMS, Bruce WR. Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet. 1997; 29:69-76.
35. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: The Japan public health center-based prospective study. International Journal of Cancer. 2007; 120(9):2007-2012.
36. Bruce WR, Giacca A, Medline A. Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiology Biomarkers & Prevention. 2000; 9(12):1271-1279.
37. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C. Obesity is an independent prognostic variable in colon cancer survivors. Clinical Cancer Research. 2010; 16(6):1884-1893.
38. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocrine Reviews. 2000; 21(3):215-244.
39. Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE, et al. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiology Biomarkers & Prevention. 2005; 14(4):850-855.
40. Lukanova A, Zeleniuch Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP-1,-2 and-3 and risk of endometrial cancer. International Journal of Cancer. 2004; 108(2):262-268.
41. Arkani M, Safaei A, Karimi K, Arbabi E, Rostami F, Iman M, et al. Association of the insulin gene polymorphism and colorectal cancer. Koomesh. 2012; 13(2):172-176.
42. Kiunga GA, Raju J, Sabljic N, Bajaj G, Good CK, Bird RP. Elevated insulin receptor protein expression in experimentally induced colonic tumors. Cancer letters. 2004; 211(2):145-153.
43. Meilleur KG, Doumatey A, Huang H, Charles B, Chen G, Zhou J, et al. Circulating adiponectin is associated with obesity and serum lipids in West Africans. Journal of Clinical Endocrinology & Metabolism. 2010; 95(7):3517-3521.
44. Blüher M, Bullen Jr JW, Lee JH, Kralisch S, Fasshauer M, Klöting N, et al. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. Journal of Clinical Endocrinology & Metabolism. 2006; 91(6):2310-2316.
45. Yamaji T, Iwasaki M, Sasazuki S, Tsugane S. Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer research. 2010; 70(13):5430-5437.
46. Gonullu G, Kahraman H, Bedir A, Bektas A, Yücel I. Association between adiponectin, resistin, insulin resistance, and colorectal tumors. International journal of colorectal disease. 2010; 25(2):205-212.
47. Otake S, Takeda H, Fujishima S, Fukui T, Orii T, Sato T, et al. Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World journal of gastroenterology: WJG. 2010; 16(10):1252.
48. Byeon JS, Jeong JY, Kim MJ, Lee SM, Nam WH, Myung SJ, et al. Adiponectin and adiponectin receptor in relation to colorectal cancer progression. International Journal of Cancer. 2010; 127(12):2758-2767.
49. Mutoh M, Teraoka N, Takasu S, Takahashi M, Onuma K, Yamamoto M, et al. Loss of Adiponectin Promotes Intestinal Carcinogenesis in Min and Wild-type Mice. Gastroenterology. 2011; 140(7):2000-2008.
50. Moon HS, Chamberland JP, Aronis K, Tseleni-Balafouta S, Mantzoros CS. Direct role of adiponectin and adiponectin receptors in endometrial cancer: in vitro and ex vivo studies in humans. Molecular cancer therapeutics. 2011; 10(12):2234-2243.
51. Liu L, Zhong R, Wei S, Yin JY, Xiang H, Zou L, et al. Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer. PLoS One. 2011; 6(11): 27301.
52. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003; 423(6941):762-769.
53. Luo Z, Saha AK, Xiang X, Ruderman NB. AMPK, the metabolic syndrome and cancer. Trends in pharmacological sciences. 2005; 26(2):69-76.
54. Williams CJ, Mitsiades N, Sozopoulos E, Hsi A, Wolk A, Nifli AP, et al. Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocrine-related cancer. 2008; 15(1):289-299.
55. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, et al. Adiponectin and breast cancer risk. Journal of Clinical Endocrinology & Metabolism. 2004; 89(3):1102-1107.
56. Kaklamani VG, Wisinski KB, Sadim M, Gulden C, Do A, Offit K, et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA: the journal of the American Medical Association. 2008; 300(13):1523-1531.
57. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews Cancer. 2004; 4(8):579-591.
58. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999; 100(25):2473-2476.
59. Rose D, Komninou D, Stephenson G. Obesity, adipocytokines, and insulin resistance in breast cancer. Obesity reviews. 2004; 5(3):153-165.
60. Karimi K, Arkani M, Safaei A, Vahedi M, Mohebi SR, Fatemi SR, et al. Association of adiponectin receptor 1 rs2275738 with colorectal cancer. Scientific journal of hamadan university of medical sciences and health services. 2012; 19(2):54-57.
61. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends in Endocrinology & Metabolism. 2000;11(8):327-332.
62. Alexe DM, Petridou E. Leptin and cancer. Leptin. 2007:201:23.
63. Tamakoshi K, Toyoshima H, Wakai K, Kojima M, Suzuki K, Watanabe Y, et al. Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan. Oncology. 2005; 68(4-6):454-461.
64. Stattin P, Lukanova A, Biessy C, Söderberg S, Palmqvist R, Kaaks R, et al. Obesity and colon cancer: does leptin provide a link? International Journal of Cancer. 2004; 109(1):149-152.
65. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology & Metabolism. 2004; 89(6):2548-2556.
66. Hardwick JCH, Van Den Brink GR, Offerhaus G, Van Deventer SJH, Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterology. 2001; 121(1):79-90.
67. Rouet-Benzineb P, Aparicio T, Guilmeau S, Pouzet C, Descatoire V, Buyse M, et al. Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-κB signaling. Journal of Biological Chemistry. 2004; 279(16):16495-16502.
68. Slattery ML, Potter J, Caan B, Edwards S, Coates A, Ma KN, et al. Energy balance and colon cancer- beyond physical activity. Cancer research. 1997; 57(1):75-80.
69. Slattery M, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes and Control. 2003; 14(1):75-84.
70. Slattery ML, Caan BJ, Benson J, Murtaugh M. Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index. Nutrition and cancer. 2003; 46: 71-166.
71. Macaulay V. Insulin-like growth factors and cancer. British journal of cancer. 1992; 65(3):311.
72. Liu L, Zhong R, Wei S, Xiang H, Chen J, Xie D, et al. The leptin gene family and colorectal cancer: interaction with smoking behavior and family history of cancer. PLoS One. 2013; 8(4):e60777.
73. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004; 363(9418):1346.
74. Ferry Jr RJ, Cerri RW, Cohen P. Insulin-like growth factor binding proteins: new proteins, new functions. Hormone Research in Paediatrics. 1999; 51(2):53-67.
75. Pike G, Vo H. The Genetic Engineering of Humans. 2009. [http://www.cs.ucdavis.edu/~rogaway/classes/188/fall07/p28.pdf.]
76. Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, et al. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Archives of physiology and biochemistry. 2008; 114(1):23-37.
77. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS letters. 2006; 580(12):2917.
78. Okamoto Y, Kihara S, Funahashi T, Matsuzawa Y, Libby P. Adiponectin: a key adipocytokine in metabolic syndrome. Clinical Science. 2006; 110(3):267-278.
79. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocrine Reviews. 2005; 26(3):439-451.
80. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Annals of internal medicine. 1999; 130(8):671.
81. Hamilton BS, Paglia D, Kwan AY, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature me
82. Sharma K, McCue P, Dunn SR. Diabetic kidney disease in the db/dbmouse. American Journal of Physiology-Renal Physiology. 2003; 284(6):F1138-F1144.